MicroBLITZ in R/R NHBCell l Lymphomas (BMS CA209-8M7) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out microtransplantation (MST) combined with the study drug nivolumab is safe and effective for patients with relapsed or refractory B cell lymphomas.
Relapsed or Refractory B Cell Lymphomas
Who Can Participate in the Study?
Adults who have relapsed/refractory B cell lymphomas
What is Involved?
If you choose to be in the study you will be asked to go through a medical screening that includes a physical, a heart test (EKG and Echo) and a breathing test.
If still eligible you will be asked to:
-Take the study medication as directed
-Complete about 6 CT or PET Scans (Body scans) over 2 years